BETonMACE Placebo Estimate
|
10
|
Resverlogix Corp.
|
Feb 19, 2019 05:36PM
|
Re: BETonMACE Placebo Estimate
|
5
|
Resverlogix Corp.
|
Feb 20, 2019 12:21PM
|
Re: BETonMACE Placebo Estimate
|
2
|
Resverlogix Corp.
|
Feb 20, 2019 01:00PM
|
Re: BETonMACE Placebo Estimate
|
2
|
Resverlogix Corp.
|
Feb 20, 2019 01:22PM
|
Re: BETonMACE Placebo Estimate
|
2
|
Resverlogix Corp.
|
Feb 20, 2019 04:16PM
|
Re: The glucose effect?
|
2
|
Resverlogix Corp.
|
Feb 21, 2019 02:45PM
|
Re: BETonMACE Enrollment
|
1
|
Resverlogix Corp.
|
Feb 22, 2019 03:52PM
|
Re: BETonMACE Enrollment
|
1
|
Resverlogix Corp.
|
Feb 22, 2019 04:25PM
|
Re: BETonMACE Enrollment
|
1
|
Resverlogix Corp.
|
Feb 22, 2019 04:28PM
|
Re: BETonMACE Enrollment
|
1
|
Resverlogix Corp.
|
Feb 22, 2019 04:29PM
|
Re: BETonMACE Enrollment
|
1
|
Resverlogix Corp.
|
Feb 22, 2019 04:29PM
|
Re: BETonMACE Enrollment
|
2
|
Resverlogix Corp.
|
Feb 22, 2019 08:09PM
|
Apabetalone's impact on blood pressure
|
1
|
Resverlogix Corp.
|
Feb 23, 2019 01:05PM
|
Re: BETonMACE Enrollment
|
|
Resverlogix Corp.
|
Feb 23, 2019 01:14PM
|
Re: New Apabetalone Clinical Trial for Pulmonary Arterial Hypertension
|
3
|
Resverlogix Corp.
|
Feb 23, 2019 03:16PM
|
When to expect the 250th Event
|
5
|
Resverlogix Corp.
|
Feb 26, 2019 01:43PM
|
Re: When to expect the 250th Event
|
1
|
Resverlogix Corp.
|
Feb 27, 2019 10:20AM
|
Thoughts on PX: Calm down
|
5
|
Resverlogix Corp.
|
Mar 15, 2019 01:11PM
|
Re: ACC 2019 Abstracts
|
3
|
Resverlogix Corp.
|
Mar 20, 2019 11:48AM
|
Re: ACC 2019 Abstracts
|
1
|
Resverlogix Corp.
|
Mar 21, 2019 11:59AM
|